School of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
Invest Ophthalmol Vis Sci. 2024 Apr 1;65(4):16. doi: 10.1167/iovs.65.4.16.
Achromatopsia (ACHM) is an autosomal recessive retinal disease associated with reduced or absent cone function. There is debate regarding the extent to which cone structure shows progressive degeneration in patients with ACHM. Here, we used optical coherence tomography (OCT) images to evaluate outer nuclear layer (ONL) thickness and ellipsoid zone (EZ) integrity over time in individuals with ACHM.
Sixty-three individuals with genetically confirmed ACHM with follow-up ranging from about 6 months to 10 years were imaged using either Bioptigen or Cirrus OCT. Foveal cone structure was evaluated by assessing EZ integrity and ONL thickness.
A total of 470 OCT images were graded, 243 OD and 227 OS. The baseline distribution of EZ grades was highly symmetrical between eyes (P = 0.99) and there was no significant interocular difference in baseline ONL thickness (P = 0.12). The EZ grade remained unchanged over the follow-up period for 60 of 63 individuals. Foveal ONL thickness showed a clinically significant change in only 1 of the 61 individuals analyzed, although detailed adaptive optics imaging revealed no changes in cone density in this individual.
ACHM appears to be a generally stable condition, at least over the follow-up period assessed here. As cones are the cellular targets for emerging gene therapies, stable EZ and ONL thickness demonstrate therapeutic potential for ACHM, although other aspects of the visual system need to be considered when determining the best timing for therapeutic intervention.
全色盲(ACHM)是一种常染色体隐性视网膜疾病,与锥体细胞功能降低或缺失有关。关于 ACHM 患者的锥体细胞结构是否存在进行性退化,目前仍存在争议。在这里,我们使用光学相干断层扫描(OCT)图像来评估 ACHM 个体的外核层(ONL)厚度和椭圆体带(EZ)完整性随时间的变化。
对 63 名经基因证实的 ACHM 患者进行了随访,随访时间从大约 6 个月到 10 年不等,使用 Bioptigen 或 Cirrus OCT 进行成像。通过评估 EZ 完整性和 ONL 厚度来评估中央凹锥体细胞结构。
共对 470 张 OCT 图像进行了分级,其中 243 只为右眼,227 只为左眼。双眼之间 EZ 分级的基线分布高度对称(P=0.99),且双眼基线 ONL 厚度无显著差异(P=0.12)。在 63 名患者中,有 60 名患者的 EZ 分级在随访期间保持不变。在 61 名接受分析的患者中,仅有 1 名患者的中央凹 ONL 厚度出现了临床显著变化,尽管详细的自适应光学成像显示该患者的锥体细胞密度没有变化。
ACHM 似乎是一种相对稳定的疾病,至少在本研究评估的随访期间是如此。由于锥体是新兴基因治疗的细胞靶标,因此 EZ 和 ONL 厚度的稳定表明 ACHM 具有治疗潜力,尽管在确定治疗干预的最佳时机时,还需要考虑视觉系统的其他方面。